The lateral lumbar interbody fusion (LLIF) market is the fastest growing minimally invasive interbody segment in the Asia-Pacific region. In particular, LLIF procedures are expected to increase at a CAGR of over 24% in South Korea over the forecast period.
LLIF procedures are fusions that are performed using a lateral MIS approach. The major driving force behind market growth in MIS interbody devices is the perceived physiological benefit to patients. These include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to normal routines. While both MIS interbody fusion and thoracolumbar fixation markets are expected to grow quickly over the forecast period, the rapid expansion of lateral lumbar interbody fusion procedures is expected to drive rapid growth in the MIS interbody fusion market.